Aortic augmentation index: Reference values in a large unselected population by means of the sphygmocor device

American Journal of Hypertension

Volumn 23, Issue 2, 2010, Pages 180-185

  Janner, Julie H ^a   Godtfredsen, Nina S ^b   Ladelund, Steen ^a   Vestbo, Jørgen ^c   Prescott, Eva ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

AIx; Arterial stiffness; Augmentation index; Blood pressure; Cardiovascular disease; Epidemiology; Hypertension; Reference values

Indexed keywords

ADULT; AGE; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BODY HEIGHT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; REFERENCE VALUE; RISK ASSESSMENT; SEX DIFFERENCE; SEX RATIO; SPHYGMOMANOMETER; SPHYGMOMANOMETRY; STROKE;

ADULT; AGE FACTORS; AGED; ALGORITHMS; ARTERIES; BODY HEIGHT; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HEALTH SURVEYS; HEART RATE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POPULATION; PREDICTIVE VALUE OF TESTS; PULSATILE FLOW; REFERENCE VALUES; SEX FACTORS; SMOKING; SOCIOECONOMIC FACTORS;

EID: 75549084082     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.234     Document Type: Article

References (32)

1. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
2. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002; 15:426-444. (Pubitemid 34478483)
3. O'Rourke M F, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension 2005; 45: 652-658.
4. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005; 45:1050-1055.
5. Nichols WW, O'Rourke M F. McDonald's Blood Flow in Arteries, 5th edn. Hodder Arnold: London, 2005.
6. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46:1753-1760.
7. O'Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. Br J Clin Pharmacol 2001; 51:507-522.
8. London GM, Blacher J, Pannier B, Guérin A P, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38:434-438.
9. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; European Network for Non-Invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
10. van Trijp MJ, Bos WJ, Uiterwaal CS, Oren A, Vos LE, Grobbee DE, Bots ML. Determinants of augmentation index in young men: the ARYA study. Eur J Clin Invest 2004; 34:825-830.
11. Vyas M, Izzo JL Jr, Lacourcière Y, Arnold JM, Dunlap ME, Amato JL, Pfeffer MA, Mitchell GF. Augmentation index and central aortic stiffness in middle-aged to elderly individuals. Am J Hypertens 2007; 20:642-647.
12. Van Trijp MJ, Uiterwaal CS, Bos WJ, Oren A, Grobbee DE, Bots ML. Noninvasive arterial measurements of vascular damage in healthy young adults: relation to coronary heart disease risk. Ann Epidemiol 2006; 16:71-77.
13. van Trijp MJ, Bos WJ, van der Schouw YT, Muller M, Grobbee DE, Bots ML. Non-invasively measured structural and functional arterial characteristics and coronary heart disease risk in middle aged and elderly men. Atherosclerosis 2006; 187:110-115.
14. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109:184-189.
15. Weber T, Auer J, O'rourke MF, Kvas E, Lassnig E, Lamm G, Stark N, Rammer M, Eber B. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J 2005; 26:2657-2663.
16. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS, Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004; 43: 1239-1245.
17. Fantin F, Mattocks A, Bulpitt CJ, Banya W, Rajkumar C. Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing 2007; 36:43-48.
18. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997; 95:1827-1836.
19. Gallagher D, Adji A, O'Rourke MF. Validation of the transfer function technique for generating central from peripheral upper limb pressure waveform. Am J Hypertens 2004; 17:1059-1067.
20. O'Rourke MF, Pauca AL. Augmentation of the aortic and central arterial pressure waveform. Blood Press Monit 2004; 9:179-185.
21. Conroy RM, Pyörälä K, Fitzgerald A P, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE Project Group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003.
22. Harrell FE Jr. Regression Modeling Strategies. Springer: Heidelberg, Germany, 2001.
23. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54:774-781.
24. Gatzka CD, Kingwell BA, Cameron JD, Berry KL, Liang YL, Dewar EM, Reid CM, Jennings GL, Dart AM; ANBO2 Investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor-and Diuretic-Based Treatment of Hypertension in the Elderly. Gender differences in the timing of arterial wave reflection beyond differences in body height. J Hypertens 2001; 19:2197-2203.
25. Wojciechowska W, Staessen JA, Nawrot T, Cwynar M, Seidlerová J, Stolarz K, Gasowski J, Tichá M, Richart T, Thijs L, Grodzicki T, Kawecka-Jaszcz K, Filipovský J; European Project on Genes in Hypertension (EPOGH)Investigators. Reference values in white Europeans for the arterial pulse wave recorded by means of the SphygmoCor device. Hypertens Res 2006; 29:475-483.
26. Namasivayam M, McDonnell BJ, McEniery CM, O'Rourke MF; Anglo-Cardiff Collaborative Trial Study Investigators. Does wave reflection dominate age-related change in aortic blood pressure across the human life span? Hypertension 2009; 53:979-985.
27. Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, Levy T, Cockcroft JR. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002; 15:24-30.
28. Li Y, Staessen JA, Li LH, Huang Q F, Lu L, Wang JG. Reference values for the arterial pulse wave in Chinese. Am J Hypertens 2008; 21:668-673.
29. Nürnberger J, Keflioglu-Scheiber A, Opazo Saez AM, Wenzel RR, Philipp T, Schäfers RF. Augmentation index is associated with cardiovascular risk. J Hypertens 2002; 20:2407-2414.
30. Hope SA, Meredith IT, Cameron JD. Arterial transfer functions and the reconstruction of central aortic waveforms: myths, controversies and misconceptions. J Hypertens 2008; 26:4-7.
31. Begg D P, Sinclair AJ, Stahl LA, Garg ML, Jois M, Weisinger RS. Dietary protein level interacts with ω-3 polyunsaturated fatty acid deficiency to induce hypertension. Am J Hypertens 2010; 23:125-128.
32. Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 2008; 7:37.